'WHO eases rules on India-made meningitis vaccine'
Agencies: Washington, Nov 16 2012, 20:47 IST
for over 20 years," said Dr Michel Zaffran, director of Optimise, the PATH-WHO collaboration aimed at improving immunisation systems and technologies.
"But this is the first time that a vaccine intended for use in Africa has been tested and submitted to regulatory review and approved for this type of use. And we expect this announcement to build momentum for applying the CTC concept to other vaccines and initiatives, allowing us to save more lives in low-income countries," Zaffran said.
Evidence of the heat stability of MenAfriVac was validated by a team of experts from WHO, PATH, SIIL, and Health Canada.
Previous Story Marketing spend lifts Paddy Power Q3 revenues Next Story S.Korea Q3 disposable income growth speeds up
Reader's Comments| Post a Comment
Be the first to comment.
